Align Technology, Inc. (ALGN)
| Market Cap | 11.72B -10.7% |
| Revenue (ttm) | 4.10B +2.9% |
| Net Income | 429.89M +5.0% |
| EPS | 5.95 +8.2% |
| Shares Out | 71.62M |
| PE Ratio | 27.49 |
| Forward PE | 14.31 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 844,544 |
| Open | 162.90 |
| Previous Close | 163.04 |
| Day's Range | 161.17 - 165.48 |
| 52-Week Range | 122.00 - 208.31 |
| Beta | 1.69 |
| Analysts | Buy |
| Price Target | 209.07 (+27.79%) |
| Earnings Date | Apr 29, 2026 |
About ALGN
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company’s Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. T... [Read more]
Financial Performance
In 2025, Align Technology's revenue was $4.03 billion, an increase of 0.90% compared to the previous year's $4.00 billion. Earnings were $410.35 million, a decrease of -2.61%.
Financial StatementsAnalyst Summary
According to 16 analysts, the average rating for ALGN stock is "Buy." The 12-month stock price target is $209.07, which is an increase of 27.79% from the latest price.
News
Align Technology to open manufacturing facility in Hyderabad, India
Align Technology (ALGN) announced plans to open a new manufacturing facility in Hyderabad, India in 2027, create more than 300 direct jobs, and spend approximately $200M in both capital and…
Align Technology Expands Global Operations With Plans for New Multi-Million Dollar Manufacturing Facility in Hyderabad, India
HYDERABAD, India & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear a...
Align plans to build new manufacturing plant in Hyderabad, Telangana Today says
Align Technology (ALGN) intends to build a new manufacturing facility in Hyderabad, India, Telangana Today reports. The company signed an MoU for the plant and plans to invest nearly Rs…
Align Technology Hosts 400 Doctors at 2026 Invisalign® EMEA Ortho Summit Featuring Digital Orthodontic Solutions Focused on Clinical Indications and Upcoming Align Innovations
BARCELONA, Spain & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear a...
Align Technology to Speak at Upcoming Financial Conferences
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, ...
Align Technology announces $200M open market repurchase
Align Technology (ALGN) announced that it is planning to repurchase $200M of Align’s common stock through open market repurchases under Align’s $1B stock repurchase program that was approved by Align’...
Align Technology Announces $200 Million Open Market Repurchase
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, ...
Align Technology Showcases Latest Advances in Integrated Digital Orthodontics and Previews 2026 Innovation at AAO Annual Session
ORLANDO, Fla. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear alig...
Align Technology price target raised to $220 from $200 at Evercore ISI
Evercore ISI analyst Elizabeth Anderson raised the firm’s price target on Align Technology (ALGN) to $220 from $200 and keeps an Outperform rating on the shares.
Align Technology beats quarterly estimates, plans $200 million buyback
Align Technology beat Wall Street estimates for first-quarter profit, aided by strong demand for its dental aligners, and announced a $200 million share buyback program, sending shares up as much as...
Align Technology reports Q1 EPS $2.58, consensus $2.29
Reports Q1 revenue $1.04B, consensus $1.02B. Commenting on Align’s Q1’26 results, Align Technology (ALGN) President and CEO Joe Hogan said, “We’re pleased to report another better-than-expected quarte...
Align Technology expects to repurchase additional $200M stock over 6 months
In August 2025, Align announced its intention to repurchase $200.0 million of common stock under its previously authorized $1.0 billion stock repurchase program. Between August 2025 and January 2026, ...
Align Technology Earnings Call Transcript: Q1 2026
Q1 2026 revenue grew 6.2% year-over-year to $1.04B, led by record clear aligner volumes and strong international growth. Guidance for FY 2026 is reaffirmed, with continued margin expansion and disciplined capital allocation amid macro uncertainty.
Align Technology Earnings release: Q1 2026
Align Technology released its Q1 2026 earnings on April 29, 2026, summarizing the period's financial results.
Align Technology Slides: Q1 2026
Align Technology has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 29, 2026.
Align Technology Quarterly report: Q1 2026
Align Technology has published its Q1 2026 quarterly earnings report on April 29, 2026.
Align Technology Announces First Quarter 2026 Financial Results, $200M Stock Repurchase, and Reaffirms Fiscal 2026 Guidance
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ int...
Align Technology price target raised to $188 from $169 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Align Technology (ALGN) to $188 from $169 and keeps an Equal Weight rating on the shares. The firm’s U.S. dental survey suggests…
Align Technology price target raised to $235 from $220 at Piper Sandler
Piper Sandler analyst Jason Bednar raised the firm’s price target on Align Technology (ALGN) to $235 from $220 and keeps an Overweight rating on the shares. Based on the firm’s…
Align Technology Proxy statement: Proxy filing
Align Technology filed a proxy statement on April 17, 2026, providing details for shareholder voting and corporate governance matters.
Align Technology Recognized for the Fifth Consecutive Year as a LexisNexis Top 100 Global Innovator, Earning “Five-Year Top 100 Global Innovator” Distinction
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ int...
Align Technology initiated with a Buy at Citi
Citi analyst Daniel Grosslight initiated coverage of Align Technology (ALGN) with a Buy rating and $240 price target The firm launched the animal health and dental sectors with a “cautiously…
Align Technology added to ‘Tactical Outperform’ list at Evercore ISI
Evercore ISI made several price target adjustments and additions to the firm’s Tactical call lists as part of the firm’s healthcare technology and distribution preview for Q1. The firm added…
Align Technology Proxy statement: Proxy filing
Align Technology filed a proxy statement on April 7, 2026, providing details for shareholder voting and corporate governance matters.
Align Technology Proxy statement: Proxy filing
Align Technology filed a proxy statement on April 7, 2026, providing details for shareholder voting and corporate governance matters.